Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19592405 | 0.80 | ALOX15 (0.35) | ALDH1A1ALOX15CYP1B1LMNATSHR | |
| SCHEMBL22882350 | 0.78 | ESR2 (0.36) | ALDH1A1ALOX15CYP1B1LMNACA1 | |
| SCHEMBL14278527 | 0.78 | ESR2 (0.36) | ALDH1A1ALOX15CYP1B1LMNACA1 | |
| SCHEMBL1245775 | 0.78 | ESR2 (0.36) | ALDH1A1ALOX15CYP1B1LMNACA1 | |
| SCHEMBL21402015 | 0.77 | — | — | |
| SCHEMBL24421017 | 0.76 | ALOX15 (0.33) | ALDH1A1ALOX15CYP1B1LMNACA1 | |
| SCHEMBL22273572 | 0.76 | ALDH1A1 (0.41) | ALDH1A1ALOX15CYP1B1LMNACA1 | |
| SCHEMBL20054809 | 0.76 | EPHX2 (0.31) | ALDH1A1ALOX15CYP1B1 | |
| SCHEMBL6899942 | 0.74 | ALOX15 (0.32) | ALDH1A1ALOX15CYP1B1LMNA | |
| SCHEMBL25207928 | 0.73 | ALOX15 (0.32) | ALDH1A1ALOX15CYP1B1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2802326-B1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2018-04-18 | — | — | EP | disclosed |